Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Athens
About this trial
Olive extracts are considered to have antioxidant properties. The investigators will study the effect of olive extracts containing hydroxytyrosol (HT)-olivomed and combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - olivomedSmart on endothelial, cardiac and vascular function in patients with coronary artery disease .
Eligibility criteria
Qualifiers
Age <70 years
Stable coronary heart disease
Patients with acute coronary syndrome who have undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), 2 months must have passed since the incident
High LDL levels, low HDL, high triglycerides
Disqualifiers
Age> 70 years
Patient with diabetes
Patient with hypertension
Patient with liver disease
Trial design
Treatments tested in this trial
- Olivomed (capsules containing hydroxytyrosol)
- OlivomedSmart - Capsules containing - combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - (OL:HT:OC 2:1:3), (5 mg HT bid).
Treatment groups
30 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov